Special Issue

Gene Therapy and Stem Cells Therapy in Cardiovascular Diseases

Submission Deadline: 31 Oct 2022

Guest Editors

  • Portrait of Guest Editor Rajesh Katare

    Rajesh Katare MBBS, PhD

    Department of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand

    Interests: microRNA; gene therapy; stem cells; chronic heart failure; diabetes mellitus; cardiomyopathy; tissue engineering

    Special Issue in IMR Press journals

  • Portrait of Guest Editor Venkata Naga Srikanth Garikipati

    Venkata Naga Srikanth Garikipati PhD

    Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

    Interests: circular RNA; snoRNA; miRNA; gene therapy; extracellular vesicles; stem cells; myocardial infarction

Special Issue Information

Dear Colleagues,

It is our great pleasure and honor to announce this Special Issue on “Gene Therapy and Stem Cell Therapy in Cardiovascular Disease.” Cardiovascular disease is the leading cause of death in several developed countries and is worsened when associated with comorbidities such as diabetes and hypertension. In recent years, major advances in gene therapy, stem cell therapy and extracellular vesicle (cell-free) therapy have allowed the development of novel therapies to treat cardiovascular diseases. This special issue is devoted to presenting the current evidence in favor of using gene and stem cell therapy for regeneration of the diseased heart.
The topics of interest include but are not limited to:

•    Therapeutic modulation of genes of interest
•    non-coding RNA-based therapies (microRNA, circular RNA, snoRNA, etc.)
•    Stem cell-based therapies (embryonic, adult, and induced pluripotent stem cells, etc.)
•    Extracellular vesicles
•    In vivo differentiation of stem cells
•    Nanoparticles/microparticles incorporated with gene or stem cells
•    Post-ischemic regeneration using gene/stem cell therapies

Assoc. Prof. Rajesh Katare and Dr. Venkata Naga Srikanth Garikipati
Guest Editors

Keywords

  • ischemic heart disease
  • diabetic heart disease
  • cardiomyopathy
  • angiogenesis
  • stem cells
  • extracellular vesicles
  • gene therapy
  • regenerative medicine
  • microRNA
  • circular RNA
  • snoRNA
  • pluripotent stem cells
  • adult stem cells
  • induced pluripotent stem cells

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. 

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.